The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global HIV Diagnostic Test Market Research Report 2025
Synopsis
HIV diagnosis tests are carried out to detect the presence of the virus.
The global HIV Diagnostic Test market was valued at US$ 4215 million in 2023 and is anticipated to reach US$ 7855 million by 2030, witnessing a CAGR of 9.2% during the forecast period 2024-2030.
The HIV diagnostic test market is driven by the increasing prevalence of HIV/AIDS and the growing focus on early detection and management of the disease. HIV diagnostic tests are essential tools used to identify the presence of the human immunodeficiency virus (HIV) in blood or saliva samples. The rise in the global burden of HIV/AIDS and the need for timely diagnosis to initiate antiretroviral therapy contribute to market growth. Moreover, advancements in testing technology, such as rapid and point-of-care tests, have improved the accessibility and efficiency of HIV diagnostics. However, the market also faces challenges, including the stigma associated with HIV testing and the need for increased awareness and access to testing in high-risk populations. Additionally, addressing the variability of HIV strains and ensuring the accuracy and sensitivity of diagnostic tests can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and reliable HIV diagnostic tests, collaborate with healthcare providers and public health agencies to expand testing initiatives, and address the challenges to meet the increasing demand for effective HIV detection and management solutions.
This report aims to provide a comprehensive presentation of the global market for HIV Diagnostic Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Diagnostic Test.
Report Scope
The HIV Diagnostic Test market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HIV Diagnostic Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV Diagnostic Test manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Healthcare
BD Biosciences
Roche Diagnostics
Zyomyx Incorporation
Merck
Bristol –Myres Squibb
J &J
Hologic Incorporation
Chembio Diagnostic Systems
Sysmex
Gilead Sciences
Qiagen
Segment by Type
Antibody Test
HIV-1 Test
Other
Segment by Application
Hospitals
Diagnostics Laboratories
Blood Banks
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HIV Diagnostic Test manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HIV Diagnostic Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
HIV diagnosis tests are carried out to detect the presence of the virus.
The global HIV Diagnostic Test market was valued at US$ 4215 million in 2023 and is anticipated to reach US$ 7855 million by 2030, witnessing a CAGR of 9.2% during the forecast period 2024-2030.
The HIV diagnostic test market is driven by the increasing prevalence of HIV/AIDS and the growing focus on early detection and management of the disease. HIV diagnostic tests are essential tools used to identify the presence of the human immunodeficiency virus (HIV) in blood or saliva samples. The rise in the global burden of HIV/AIDS and the need for timely diagnosis to initiate antiretroviral therapy contribute to market growth. Moreover, advancements in testing technology, such as rapid and point-of-care tests, have improved the accessibility and efficiency of HIV diagnostics. However, the market also faces challenges, including the stigma associated with HIV testing and the need for increased awareness and access to testing in high-risk populations. Additionally, addressing the variability of HIV strains and ensuring the accuracy and sensitivity of diagnostic tests can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and reliable HIV diagnostic tests, collaborate with healthcare providers and public health agencies to expand testing initiatives, and address the challenges to meet the increasing demand for effective HIV detection and management solutions.
This report aims to provide a comprehensive presentation of the global market for HIV Diagnostic Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Diagnostic Test.
Report Scope
The HIV Diagnostic Test market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HIV Diagnostic Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV Diagnostic Test manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Healthcare
BD Biosciences
Roche Diagnostics
Zyomyx Incorporation
Merck
Bristol –Myres Squibb
J &J
Hologic Incorporation
Chembio Diagnostic Systems
Sysmex
Gilead Sciences
Qiagen
Segment by Type
Antibody Test
HIV-1 Test
Other
Segment by Application
Hospitals
Diagnostics Laboratories
Blood Banks
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HIV Diagnostic Test manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HIV Diagnostic Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 HIV Diagnostic Test Market Overview
1.1 Product Overview and Scope of HIV Diagnostic Test
1.2 HIV Diagnostic Test Segment by Type
1.2.1 Global HIV Diagnostic Test Market Value Comparison by Type (2024-2030)
1.2.2 Antibody Test
1.2.3 HIV-1 Test
1.2.4 Other
1.3 HIV Diagnostic Test Segment by Application
1.3.1 Global HIV Diagnostic Test Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 Blood Banks
1.3.5 Others
1.4 Global HIV Diagnostic Test Market Size Estimates and Forecasts
1.4.1 Global HIV Diagnostic Test Revenue 2019-2030
1.4.2 Global HIV Diagnostic Test Sales 2019-2030
1.4.3 Global HIV Diagnostic Test Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 HIV Diagnostic Test Market Competition by Manufacturers
2.1 Global HIV Diagnostic Test Sales Market Share by Manufacturers (2019-2024)
2.2 Global HIV Diagnostic Test Revenue Market Share by Manufacturers (2019-2024)
2.3 Global HIV Diagnostic Test Average Price by Manufacturers (2019-2024)
2.4 Global HIV Diagnostic Test Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HIV Diagnostic Test, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HIV Diagnostic Test, Product Type & Application
2.7 HIV Diagnostic Test Market Competitive Situation and Trends
2.7.1 HIV Diagnostic Test Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest HIV Diagnostic Test Players Market Share by Revenue
2.7.3 Global HIV Diagnostic Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HIV Diagnostic Test Retrospective Market Scenario by Region
3.1 Global HIV Diagnostic Test Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global HIV Diagnostic Test Global HIV Diagnostic Test Sales by Region: 2019-2030
3.2.1 Global HIV Diagnostic Test Sales by Region: 2019-2024
3.2.2 Global HIV Diagnostic Test Sales by Region: 2025-2030
3.3 Global HIV Diagnostic Test Global HIV Diagnostic Test Revenue by Region: 2019-2030
3.3.1 Global HIV Diagnostic Test Revenue by Region: 2019-2024
3.3.2 Global HIV Diagnostic Test Revenue by Region: 2025-2030
3.4 North America HIV Diagnostic Test Market Facts & Figures by Country
3.4.1 North America HIV Diagnostic Test Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America HIV Diagnostic Test Sales by Country (2019-2030)
3.4.3 North America HIV Diagnostic Test Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe HIV Diagnostic Test Market Facts & Figures by Country
3.5.1 Europe HIV Diagnostic Test Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe HIV Diagnostic Test Sales by Country (2019-2030)
3.5.3 Europe HIV Diagnostic Test Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HIV Diagnostic Test Market Facts & Figures by Country
3.6.1 Asia Pacific HIV Diagnostic Test Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific HIV Diagnostic Test Sales by Country (2019-2030)
3.6.3 Asia Pacific HIV Diagnostic Test Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America HIV Diagnostic Test Market Facts & Figures by Country
3.7.1 Latin America HIV Diagnostic Test Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America HIV Diagnostic Test Sales by Country (2019-2030)
3.7.3 Latin America HIV Diagnostic Test Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa HIV Diagnostic Test Market Facts & Figures by Country
3.8.1 Middle East and Africa HIV Diagnostic Test Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa HIV Diagnostic Test Sales by Country (2019-2030)
3.8.3 Middle East and Africa HIV Diagnostic Test Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global HIV Diagnostic Test Sales by Type (2019-2030)
4.1.1 Global HIV Diagnostic Test Sales by Type (2019-2024)
4.1.2 Global HIV Diagnostic Test Sales by Type (2025-2030)
4.1.3 Global HIV Diagnostic Test Sales Market Share by Type (2019-2030)
4.2 Global HIV Diagnostic Test Revenue by Type (2019-2030)
4.2.1 Global HIV Diagnostic Test Revenue by Type (2019-2024)
4.2.2 Global HIV Diagnostic Test Revenue by Type (2025-2030)
4.2.3 Global HIV Diagnostic Test Revenue Market Share by Type (2019-2030)
4.3 Global HIV Diagnostic Test Price by Type (2019-2030)
5 Segment by Application
5.1 Global HIV Diagnostic Test Sales by Application (2019-2030)
5.1.1 Global HIV Diagnostic Test Sales by Application (2019-2024)
5.1.2 Global HIV Diagnostic Test Sales by Application (2025-2030)
5.1.3 Global HIV Diagnostic Test Sales Market Share by Application (2019-2030)
5.2 Global HIV Diagnostic Test Revenue by Application (2019-2030)
5.2.1 Global HIV Diagnostic Test Revenue by Application (2019-2024)
5.2.2 Global HIV Diagnostic Test Revenue by Application (2025-2030)
5.2.3 Global HIV Diagnostic Test Revenue Market Share by Application (2019-2030)
5.3 Global HIV Diagnostic Test Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott Healthcare
6.1.1 Abbott Healthcare Corporation Information
6.1.2 Abbott Healthcare Description and Business Overview
6.1.3 Abbott Healthcare HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Healthcare HIV Diagnostic Test Product Portfolio
6.1.5 Abbott Healthcare Recent Developments/Updates
6.2 BD Biosciences
6.2.1 BD Biosciences Corporation Information
6.2.2 BD Biosciences Description and Business Overview
6.2.3 BD Biosciences HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BD Biosciences HIV Diagnostic Test Product Portfolio
6.2.5 BD Biosciences Recent Developments/Updates
6.3 Roche Diagnostics
6.3.1 Roche Diagnostics Corporation Information
6.3.2 Roche Diagnostics Description and Business Overview
6.3.3 Roche Diagnostics HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Diagnostics HIV Diagnostic Test Product Portfolio
6.3.5 Roche Diagnostics Recent Developments/Updates
6.4 Zyomyx Incorporation
6.4.1 Zyomyx Incorporation Corporation Information
6.4.2 Zyomyx Incorporation Description and Business Overview
6.4.3 Zyomyx Incorporation HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zyomyx Incorporation HIV Diagnostic Test Product Portfolio
6.4.5 Zyomyx Incorporation Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck HIV Diagnostic Test Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Bristol –Myres Squibb
6.6.1 Bristol –Myres Squibb Corporation Information
6.6.2 Bristol –Myres Squibb Description and Business Overview
6.6.3 Bristol –Myres Squibb HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bristol –Myres Squibb HIV Diagnostic Test Product Portfolio
6.6.5 Bristol –Myres Squibb Recent Developments/Updates
6.7 J &J
6.6.1 J &J Corporation Information
6.6.2 J &J Description and Business Overview
6.6.3 J &J HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)
6.4.4 J &J HIV Diagnostic Test Product Portfolio
6.7.5 J &J Recent Developments/Updates
6.8 Hologic Incorporation
6.8.1 Hologic Incorporation Corporation Information
6.8.2 Hologic Incorporation Description and Business Overview
6.8.3 Hologic Incorporation HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hologic Incorporation HIV Diagnostic Test Product Portfolio
6.8.5 Hologic Incorporation Recent Developments/Updates
6.9 Chembio Diagnostic Systems
6.9.1 Chembio Diagnostic Systems Corporation Information
6.9.2 Chembio Diagnostic Systems Description and Business Overview
6.9.3 Chembio Diagnostic Systems HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Chembio Diagnostic Systems HIV Diagnostic Test Product Portfolio
6.9.5 Chembio Diagnostic Systems Recent Developments/Updates
6.10 Sysmex
6.10.1 Sysmex Corporation Information
6.10.2 Sysmex Description and Business Overview
6.10.3 Sysmex HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sysmex HIV Diagnostic Test Product Portfolio
6.10.5 Sysmex Recent Developments/Updates
6.11 Gilead Sciences
6.11.1 Gilead Sciences Corporation Information
6.11.2 Gilead Sciences HIV Diagnostic Test Description and Business Overview
6.11.3 Gilead Sciences HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Gilead Sciences HIV Diagnostic Test Product Portfolio
6.11.5 Gilead Sciences Recent Developments/Updates
6.12 Qiagen
6.12.1 Qiagen Corporation Information
6.12.2 Qiagen HIV Diagnostic Test Description and Business Overview
6.12.3 Qiagen HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Qiagen HIV Diagnostic Test Product Portfolio
6.12.5 Qiagen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HIV Diagnostic Test Industry Chain Analysis
7.2 HIV Diagnostic Test Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HIV Diagnostic Test Production Mode & Process
7.4 HIV Diagnostic Test Sales and Marketing
7.4.1 HIV Diagnostic Test Sales Channels
7.4.2 HIV Diagnostic Test Distributors
7.5 HIV Diagnostic Test Customers
8 HIV Diagnostic Test Market Dynamics
8.1 HIV Diagnostic Test Industry Trends
8.2 HIV Diagnostic Test Market Drivers
8.3 HIV Diagnostic Test Market Challenges
8.4 HIV Diagnostic Test Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
